Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.47 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.47 |
| ▸ | SMN1; SMN2 | Q16637 | 5/20 | 0.45 |
| ▸ | NPC1 | O15118 | 5/20 | 0.45 |
| ▸ | RAB9A | P51151 | 5/20 | 0.45 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.45 |
| ▸ | MEN1 | O00255 | 2/20 | 0.45 |
| ▸ | POLB | P06746 | 2/20 | 0.45 |
| ▸ | HTT | P42858 | 2/20 | 0.43 |
| ▸ | SRD5A2 | P31213 | 1/20 | 0.43 |
| ▸ | MAPT | P10636 | 3/20 | 0.42 |
| ▸ | NFKB1 | P19838 | 2/20 | 0.42 |
| ▸ | NFKB2 | Q00653 | 2/20 | 0.42 |
| ▸ | RELA | Q04206 | 2/20 | 0.42 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.42 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.42 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.42 |
| ▸ | PKM | P14618 | 1/20 | 0.41 |
| ▸ | GSK3B | P49841 | 1/20 | 0.41 |
| ▸ | SLC6A3 | Q01959 | 2/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10543614 | 0.91 | ALDH1A1 (0.45) | ALDH1A1MAPK1SMN1; SMN2NPC1RAB9A | |
| SCHEMBL10545643 | 0.91 | ALDH1A1 (0.45) | ALDH1A1MAPK1SMN1; SMN2NPC1RAB9A | |
| SCHEMBL10543020 | 0.91 | ALDH1A1 (0.45) | ALDH1A1MAPK1SMN1; SMN2NPC1RAB9A | |
| SCHEMBL11378210 | 0.84 | ALDH1A1 (0.47) | ALDH1A1MAPK1SMN1; SMN2NPC1RAB9A | |
| SCHEMBL699497 | 0.76 | CFTR (0.54) | ALDH1A1MAPK1SMN1; SMN2NPC1RAB9A | |
| SCHEMBL11244427 | 0.74 | RAB9A (0.47) | ALDH1A1SMN1; SMN2NPC1RAB9AKMT2A | |
| SCHEMBL11310324 | 0.74 | TSHR (0.51) | ALDH1A1SMN1; SMN2NPC1RAB9AKMT2A | |
| SCHEMBL3443921 | 0.73 | HDAC1 (0.52) | ALDH1A1MAPK1SMN1; SMN2NPC1RAB9A | |
| SCHEMBL1684359 | 0.73 | HDAC1 (0.55) | ALDH1A1MAPK1SMN1; SMN2NPC1RAB9A | |
| SCHEMBL20088772 | 0.73 | ALDH1A1 (0.49) | ALDH1A1MAPK1SMN1; SMN2NPC1RAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20140121208-A1 | Compositions for Treatment of Cystic Fibrosis and Other Chronic Diseases | VERTEX PHARMACEUTICALS INCORPORATED (US) | 2014-05-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140121208-A1 | Compositions for Treatment of Cystic Fibrosis and Other Chronic Diseases | CFTR, SLC26A4, ABCB11 | ALDH1A1 2535/4885MAPK1 2283/4885SMN1; SMN2 3332/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.